How much revenue did Prestige Biologics Co generate this year?
Prestige Biologics Co has achieved a revenue of 1.73 B KRW this year.
Prestige Biologics Co Revenue 2024
Prestige Biologics Co Revenue
1.73 B KRW
Ticker
334970.KQ
ISIN
KR7334970001
In 2024, Prestige Biologics Co's sales reached 1.73 B KRW, a 11,015.87% difference from the 15.57 M KRW sales recorded in the previous year.
The Prestige Biologics Co Revenue history
| YEAR | REVENUE (undefined KRW) | GROSS MARGIN (%) |
|---|---|---|
| 2023 | 1.73 | 29,91 |
| 2022 | 0.02 | 23,13 |
| 2021 | 3.23 | 72,95 |
| 2020 | - | - |
| 2019 | 0.18 | 100,00 |
| 2018 | - | - |
Prestige Biologics Co Aktienanalyse
What does Prestige Biologics Co do?
Prestige Biologics Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Prestige Biologics Co's Sales Figures
The sales figures of Prestige Biologics Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Prestige Biologics Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Prestige Biologics Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Prestige Biologics Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Prestige Biologics Co Stock
How much was the turnover of the company Prestige Biologics Co compared to the previous year?
The revenue of Prestige Biologics Co has increased by 11,015.87% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Prestige Biologics Co?
The revenue of Prestige Biologics Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Prestige Biologics Co measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Prestige Biologics Co so important for investors?
The revenue of Prestige Biologics Co is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Prestige Biologics Co pay?
Over the past 12 months, Prestige Biologics Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Prestige Biologics Co is expected to pay a dividend of 0 KRW.
What is the dividend yield of Prestige Biologics Co?
The current dividend yield of Prestige Biologics Co is .
When does Prestige Biologics Co pay dividends?
Prestige Biologics Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Prestige Biologics Co?
Prestige Biologics Co paid dividends every year for the past 0 years.
What is the dividend of Prestige Biologics Co?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Prestige Biologics Co located?
Prestige Biologics Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Prestige Biologics Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Prestige Biologics Co from 6/11/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.
When did Prestige Biologics Co pay the last dividend?
The last dividend was paid out on 6/11/2024.
What was the dividend of Prestige Biologics Co in the year 2023?
In the year 2023, Prestige Biologics Co distributed 0 KRW as dividends.
In which currency does Prestige Biologics Co pay out the dividend?
The dividends of Prestige Biologics Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Prestige Biologics Co
Our stock analysis for Prestige Biologics Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Prestige Biologics Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Prestige Biologics Co Revenue
- Prestige Biologics Co Net Income
- Prestige Biologics Co P/E
- Prestige Biologics Co P/S
- Prestige Biologics Co EBIT
- Prestige Biologics Co Dividend
- Prestige Biologics Co Stocks
- Prestige Biologics Co Market capitalization
- Prestige Biologics Co Debt
- Prestige Biologics Co Liabilities
- Prestige Biologics Co Equity
- Prestige Biologics Co AAQS
- Prestige Biologics Co Employees
- Prestige Biologics Co ROE
- Prestige Biologics Co ROA
- Prestige Biologics Co ROCE